MiMedx Group Affirms FY2026 Sales Guidance of $260.000M-$290.000M vs $269.440M Est
MiMedx Group (NASDAQ: MDXG ) affirms FY2026 sales outlook from $260.000 million-$290.000 million to $260.000 million-$290.000 million vs $269.440 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.